Clinical trial
Vessels Encapsulating Tumor Clusters (VETC), Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Gland Carcinoma
NCT04666220 is registered in ClinicalTrials.gov with Humanitas Clinical and Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vessels Encapsulating Tumor Clusters (VETC), Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Gland Carcinoma
- Lead sponsor
- Humanitas Clinical and Research Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 2, 2021
- Completion date
- May 31, 2021
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adrenal carcinoma, renal cell carcinoma